glumetinib
Small moleculeexperimental
Clinical trial activity
11 trials · 20 clinical orgs · 0 marketing orgs
Phase 1
7
Phase 2
7
Phase 3
2
Phase 4
0
Earliest trial started Sep 14, 2017 (NCT03466268)
Timeline
Indications
Mechanism of action
- GTPase KRasINHIBITOR
KRAS inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06947291 | Phase 2 | Jun 4, 2025 | Shijiazhuang Pharma Group (CSPC) |
| NCT06980532 | Phase 1/Phase 2 (Phase 2) | Apr 25, 2025 | Huazhong University of Science and Technology |
| NCT06908772 | Phase 2/Phase 3 (Phase 3) | Apr 1, 2025 | Shanghai JMT-Bio Inc. |
| NCT06829459 | Phase 3 | Feb 15, 2025 | Shanghai JMT-Bio Inc. |
| NCT06525350 | Phase 2 | Jul 31, 2024 | Shijiazhuang Pharma Group (CSPC) |
| NCT04797702 | Phase 1/Phase 2 (Phase 2) | Apr 15, 2021 | Shanghai Junshi Bioscience Co.,Ltd. |
| NCT05507294 | Phase 1 | Mar 2, 2021 | ShangHai HaiHe Pharmaceutical |
| NCT04338243 | Phase 1/Phase 2 (Phase 2) | Nov 18, 2019 | Jiao Tong University, Nanjing Medical University, ShangHai HaiHe Pharmaceutical, Zhejiang University |
| NCT04270591 | Phase 1/Phase 2 (Phase 2) | Jul 15, 2019 | Anhui Medical University, Central South University, Changhai Hospital, Chinese Academy of Medical Sciences, Harbin Medical University, Hebei University, Huazhong University of Science and Technology, Jiao Tong University, Jilin University, Nanjing Medical University, People's Liberation Army of China, Shanghai Chest Hospital, Shanghai, China, ShangHai HaiHe Pharmaceutical, The Chest Hospital of Anhui Province, Zhejiang University, Zhengzhou University |
| NCT03457532 | Phase 1 | Dec 16, 2017 | ShangHai HaiHe Pharmaceutical |
| NCT03466268 | Phase 1 | Sep 14, 2017 | ShangHai HaiHe Pharmaceutical, Shantou University |
Showing 11 of 11 trials
Page 1 / 1
Organizations
Research & Development (20)
20 organizations
Page 1 / 1